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Vibrio cholerae, a Gram-negative bacterium, is the causative agent of pandemic cholera.
Previous studies have shown that the survival of the seventh pandemic El Tor biotype
V. cholerae strain N16961 requires production of acetoin in a glucose-rich environment.
The production of acetoin, a neutral fermentation end-product, allows V. cholerae
to metabolize glucose without a pH drop, which is mediated by the production of
organic acid. This finding suggests that inhibition of acetoin fermentation can result in
V. cholerae elimination by causing a pH imbalance under glucose-rich conditions. Here,
we developed a simple high-throughput screening method and identified an inducer of
medium acidification (iMAC). Of 8364 compounds screened, we identified one chemical,
5-(4-chloro-2-nitrobenzoyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, that
successfully killed glucose-metabolizing N16961 by inducing acidic stress. When
N16961 was grown with abundant glucose in the presence of iMAC, acetoin
production was completely suppressed and concomitant accumulation of lactate
and acetate was observed. Using a beta-galactosidase activity assay with a single-copy
palsD::lacZ reporter fusion, we show that that iMAC likely inhibits acetoin production
at the transcriptional level. Thin-layer chromatography revealed that iMAC causes
a significantly reduced accumulation of intracellular (p)ppGpp, a bacterial stringent
response alarmone known to positively regulate acetoin production. In vivo bacterial
colonization and fluid accumulation were also markedly decreased after iMAC treatment.
Finally, we demonstrate iMAC-induced bacterial killing for 22 different V. cholerae strains
belonging to diverse serotypes. Together, our results suggest that iMAC, acting as a
metabolic modulator, has strong potential as a novel antibacterial agent for treatment
against cholera.
Keywords: Vibrio cholerae, glucosemetabolism, acetoin,mixed acid fermentation, inducer ofmediumacidification
(iMAC)
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INTRODUCTION
Acetoin, known as 3-hydroxy-2-butanone or acetyl methyl
carbinol, is produced by various microorganisms in which
acetoin often has physiological functions required for survival
(Voloch et al., 1983; Yoon and Mekalanos, 2006; Vivijs
et al., 2014a,b). In Vibrio cholerae, enzymes, encoded by
VC1589-VC1590 locus are involved in acetoin biosynthesis.
The α-acetolactate synthase (VC1590, AlsS) catalyzes the
conversion of two molecules of pyruvate into α-acetolactate,
and α-acetolactate decarboxylase (VC1589, AlsD) subsequently
catalyzes the decarboxylation of α-acetolactate into acetoin
(Kovacikova et al., 2005; Xiao and Lu, 2014). Of additional
note, V. cholerae N16961 produces a LysR-type transcriptional
regulator (referred to as AlsR). Expression of alsR gene is induced
by environmental factors such as acetate, anaerobiosis, or low
environmental pH, and it activates the expression of the acetoin
biosynthesis genes (Renna et al., 1993;Mayer et al., 1995; Frädrich
et al., 2012). Because acetoin is a neutral fermentation end
product and this biosynthetic reaction consumes intracellular
protons, bacterial growth can occur on a glucose carbon source
without pH decrease (Thomas et al., 2014). These findings
indicate that acetoin production during fermentation plays an
important physiological role in the adaptation to acidic stress,
and it also suggests a potential mechanism to control pathogenic
bacteria like V. cholerae, that are known to be acid-sensitive
(Merrell and Camilli, 2002).
The Gram-negative bacterium V. cholerae is the etiological
agent of cholera, a life-threatening severe diarrheal disease
(Faruque et al., 1998; Sack et al., 2004). The pathogen produces
two major virulence factors: the cholera toxin (CT), which
is responsible for massive watery diarrhea by causing an
imbalance of ion transport across the intestinal epithelium; and
the toxin-coregulated pilus (TCP), which contributes to the
successful colonization of V. cholerae in the host intestine (Miller
et al., 1987; Herrington et al., 1988; Thelin and Taylor, 1996;
Childers and Klose, 2007). Previous work has demonstrated that
the seventh pandemic V. cholerae O1 El Tor biotype strains
produce acetoin, a metabolite that provides a growth advantage
under glucose-rich conditions over the classical biotype strains
(Yoon and Mekalanos, 2006). Further, it is proposed that the
production of acetoin may account for the greater evolutionary
fitness of V. cholerae El Tor biotype compared to the classical
biotype (Yoon and Mekalanos, 2006). Additionally, acetoin
production offers V. cholerae cells a survival advantage during
infection by down regulating the host innate immune responses
(Bari et al., 2011). These findings support the hypothesis that
inhibiting acetoin production could provide a novel antibacterial
mechanism for V. cholerae elimination.
In V. cholerae, there are two major regulatory mechanisms
for acetoin biosynthesis. First, acetoin production is negatively
regulated by AphA, a quorum sensing (QS)-dependent
transcriptional activator. AphA represses expression of the
acetoin biosynthetic genes by binding to a region that overlaps
the transcriptional start site of alsD (Kovacikova et al., 2005).
Meanwhile, it also reduces the expression of the divergently
transcribed alsR gene, which encodes an acetate-responsive
LysR-type regulator (Kovacikova et al., 2005). Second, recent
work from our group has shown that (p)ppGpp, a stringent
response alarmone, also plays a critical role in regulating acetoin
production. A mutant strain defective in (p)ppGpp production
lost the ability to produce acetoin and becomes inviable due
to uncontrolled production of organic acids in the presence of
glucose (Oh et al., 2015). We also demonstrated that, in the
seventh pandemic N16961 El Tor strain, (p)ppGpp-mediated
regulation is more important for maintaining bacterial viability
than the QS-dependent regulation, which is controlled in an
AphA-dependent manner (Oh et al., 2015). These findings
strongly suggest that (p)ppGpp is a promising drug target for the
inhibition of V. cholerae infection and survival.
In this study, we screened a chemical library and identified a
compound that induces medium acidification and thereby loss of
V. cholerae viability under glucose-rich conditions. Further, we
present a potential mechanism by which the compound inhibits
acetoin biosynthesis. By targeting acetoin biosynthesis, our work
provides a novel strategy to combat cholera.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were conducted following national
guidelines provided by the Korean government (Ministry
for Food, Agriculture, Forestry, and Fisheries) and in strict
accordance with the institutional guidelines for animal care
and use of laboratory animals. The methods for animal
experimentations using infant mouse were approved by the
Committee on the Ethics of Animal Experiments of the Yonsei
University College of Medicine (Permit Number 2011-0166).
Bacterial Strains and Growth Conditions
All bacteria strains used in this study are listed in Table S1. V.
cholerae strains and E. coli DH5α strain cultures were grown
at 37◦C in LB medium (LB; 1% (w/v) tryptone, 0.5% (w/v)
yeast extract, and 1% (w/v) NaCl). Vibrio vulnificus MO6-
24/O strain and Vibrio paraheamolyticus ATCC27519 strain
were grown at 30◦C in LBS [LB medium containing NaCl at
a final concentration of 2.5% (w/v)] media. A single colony
grown on an LB agar plate was picked and inoculated to start
a pre-culture. Overnight cultures were then diluted 100-fold
in LB or LBG [LB containing 1% glucose (w/v)] for the main
cultures. When necessary, 200 µg/ml streptomycin was used
for selective V. cholerae growth. Bacterial growth was measured
spectrophotometrically according to optical density at 600 nm.
The pH of the culture media was measured using a pH meter
(METTLER TOLEDO Co. pH S20-K MASA). To describe cell
viability, the number of colony forming units (CFUs) was
quantified by plating serial dilutions of bacterial cultures.
A High-Throughput Screening Assay to
Identify Inducers of Metabolism-Mediated
Acidification (iMAC)
To identify iMAC candidates, a 8364-compound library,
obtained from the Korea Chemical Bank (Daejoen, Korea), was
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 November 2016 | Volume 6 | Article 156
Oh et al. Killing Vibrio cholerae by a Metabolic Modulator
used in our screening assay. Overnight-grown bacterial cells were
diluted 100-fold in LB or LBG for primary screening cultures,
and 200 ul of each were inoculated on a 96-well plate containing
glass beads for effective aeration. Each chemical in the screen
was added in LB and LBG at 50 µM final concentration, and
cells were grown in aerobic conditions for 16 h with shaking.
To verify the pH of each culture supernatant, phenol red
(20 mg/liter; Sigma Chemical Co., St. Louis, MO) was added
to bacterial cell cultures as a pH indicator. One compound
of chemical library, 5-(4-chloro-2-nitrobenzoyl)-6-hydroxy-1,3-
dimethylpyrimidine-2,4(1H,3H)-dione (iMAC), (Figure 2A) was
selected for further study, and it was subsequently synthesized
in a large amount from the Korea Research Institute of
Chemical Technology (KRICT, Daejoen, Korea). Initial iMAC
stock solution was made at 5 mM in 10% DMSO (dimethyl
sulfoxide). Then, the stock solution was diluted in LB or LBG.
Quantification of Metabolites
To quantify the amounts of organic acids in the culture media,
bacterial cells were grown aerobically for 16 h in LB, LBG,
or LBG + 50 µM iMAC media and subsequently harvested
by centrifugation at 14,000 rpm for 10 min. The culture
supernatants were filtered using 0.22 µm-pore syringe filters
(Pall Corp., MI, USA), and samples were analyzed using high-
performance liquid chromatography (HPLC). Acetoin level was
quantitatively measured using the Voges-Proskauer (VP) test
as described previously (Kovacikova et al., 2005). Briefly, 5%
α-naphthol and 40% KOH were added to cell-free culture
supernatant, the reaction mixture was incubated for 30 min
at room temperature, and then the value of acetoin amount
was determined by measuring absorbance at 490 nm with a
spectrophotometer.
Scanning Electron Microscopy (SEM)
Overnight cultures grown in LB or LBG media with or without
50 µM iMAC were visualized by scanning electron microscopy
(SEM) in order to visualize cell morphology. For the SEM
sample preparation, cells were fixed with PBS containing 2%
glutaraldehyde and 0.1% paraformaldehyde for 2 h. Samples were
then coated with gold by an ion sputter (IB-3 Eiko, Japan) and
examined with a scanning electron microscope (FE SEM S-800,
Hitachi, Japan) at an acceleration voltage of 20 kV. Images were
processed with ESCAN 4000 software (Bummi Universe Co.,
LTD, Seoul, Korea).
Thin Layer Chromatography
Intracellular small nucleotide levels were measured as previously
described with slight modification (He et al., 2012). To detect
ppGpp concentrations, overnight-grown cultures were diluted
100-fold in LB or LB + 50 µM iMAC media supplemented with
100 µCi/ml of [32P]-orthophosphate (Perkin-Elmer, Waltham,
MA) and grown at 37◦C with shaking for 4 h. The cultures were
then extracted with 19 M formic acid. Briefly, bacterial cells were
precipitated by centrifugation to remove the cell supernatant,
after which the cell pellets were resuspended in cold 10 mM Tris-
HCl buffer (pH 8.0) and 19M formic acid and then subjected to
three freeze-thaw cycles. After further centrifugation to remove
cell debris, the supernatants were spotted on a polyethyleneimine
(PEI)-coated thin-layer chromatography (TLC) plate (Merck &
Co., Whitehouse Station, NJ). The plate was developed in 1.5M
KH2PO4 (pH 3.5) and visualized by autoradiography.
CT-ELISA and β-Galactosidase Activity
Assay
CT production was quantified by subjecting V. cholerae culture
supernatants to a GM1-enzyme-linked immunosorbent assay
(GM1-ELISA), as described previously (Gardel and Mekalanos,
1994). To collect the culture supernatant, wild-type N16961
strain growth was induced in both CT-inducible culturemethods:
anaerobic TMAO respiration condition and the AKI condition,
as described previously (Iwanaga et al., 1986). Bacterial cells were
subsequently centrifuged at 13,000 rpm and 4◦C for 20 min.
Cell-free supernatants were then collected and passed through
0.22 µm-pore syringe filters (Pall Corp., MI, USA). Purified
CT subunit B (List Biological Laboratories, Inc., Campbell,
CA) was used to provide a standard curve, and phosphate-
buffered saline (PBS) was used as a negative control. Rabbit
polyclonal anti-CT subunit B (Abcam Inc., Cambridge, UK)
and anti-rabbit immunoglobulin G conjugated with horseradish
peroxidase (Santa-Cruz Biotechnology Inc., Dallas, TX) were
used to detect the presence of CT. The promoter activity of
alsD (VC1598) was assessed bymeasuring β-galactosidase activity
in the wild-type N16961 strain containing a palsD::lacZ fusion
gene constructed previously (Oh et al., 2015). Bacterial cells were
harvested after incubation for 5 h in LB, LBG, or LBG + 50
µM iMAC, and β-galactosidase activity was assayed as described
previously (Yoon and Mekalanos, 2006).
Infant Mouse Infection
Bacterial strains were suspended in LB or LBG with or without
50 µM iMAC to a final cell density of 1 × 107 CFU/mL. Infant
mice (∼5–6 days old, Central Lab Animal Inc., Seoul) were
orogastrically infected with 50 µL of each bacterial suspension
(5 × 105 cells). After 24 h of infection, the entire intestine was
removed and homogenized in 2mL PBS. Bacterial cell viability
was determined by enumerating colony numbers of serially
diluted gut homogenates. LB agar plates supplemented with
streptomycin (100 µg/ml) were used for CFU counting. The
fluid accumulation ratio is calculated as the gut weight/remaining
body weight.
Cytotoxicity Assay
Host cell culture was performed as described previously (Bari
et al., 2011). Intestinal epithelial HT29 cells (ATCC, Rockville,
MD, USA) were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% FBS (WelGENE, Korea),
2.5mM L-glutamine, 100 U/mL penicillin, and 100 µg/mL
streptomycin at 37◦C in a 5% CO2 atmosphere in a water-
jacketed incubator (Forma Scientific, USA). Then, 2 × 105
HT29 cells were seeded per well in 6-well plates (SPL Life
Sciences, Korea) and cultured overnight. The following day,
culture media was replaced with serum-free media prior to
treatment. Various concentrations of iMAC were then added
to the host cells, and mixtures were incubated for 48 h at
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37◦C under 5% CO2. Images of viable cells were visualized
by optical microscopy. The cytotoxicity assay was performed
using colorimetric assay as described previously (Mosmann,
1983). Samples of culture media were then collected for
the cell viability assay using 3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide tetrazolium reduction assay (MTT
assay; Thiazolyl Blue Tetrazolium Bromide, Sigma) according to
the manufacturer’s instructions.
Statistical Analysis
Data are expressed as mean ± SD. Unpaired Student’s t-test
and the Wilcoxon Rank-Sum test (for animal experiments) were
used to analyze the data. A p < 0.05 (Student’s t-test) or <0.01
(Wilcoxon test) was considered statistically significant.
RESULTS
Identification of a Novel Chemical
Compound that Induces Acidification of
the Media during Glucose Metabolism
V. cholerae O1 El Tor strains grow extremely well in a
glucose-rich environment (Yoon and Mekalanos, 2006). The
uninterrupted synthesis of acetoin, a neutral fermentation
end-product, is a critical component of this robust growth.
An N16961 1alsS mutant that failed to produce acetoin lost
its viability for glucose-stimulated growth due to medium
acidification. Therefore, we expect significant therapeutic
potential if we can prevent V. cholerae cells from producing
acetoin in glucose-rich media (summarized in Figure 1A). To
this end, we designed a chemical library screening method
to search for compounds that induce acidification during
glucose-induced growth. An initial screen was performed with
8364 chemical compounds obtained from the Korea Chemical
Bank. N16961 and its 1alsS mutant were grown in LB or
LB plus 1% glucose (LBG) with each chemical compound.
Bacterial growth was monitored by measuring OD600, and
the pH of the media was measured with a pH indicator.
Schematic screening procedures are depicted in Figure 1B.
From our initial screen, we identified 24 chemicals with
the ability to induce medium acidification during N16961
growth in LBG (Figure S1A). In each case, defective growth
was concomitantly observed (Figure S1B). Compounds were
applied at a concentration of 50 µM. Bacterial growth was
not noticeably affected by these compounds in LB, suggesting
that the inhibitory effect of each of these chemicals requires
the addition of glucose. When viable cells were enumerated in
each acidified medium, a reduction in viability was invariably
observed (Figure S1C). The number of viable cells of N16961 was
∼10-fold higher after growth in LBG vs. LB (Figure S1C), further
confirming a glucose-induced effect on the active growth of
N16961.
We next sought to determine which compound most
effectively inhibits glucose-stimulated growth of N16961. To
address this issue, N16961 cells were grown with varying
concentrations (50, 25, and 12.5 µM) of each of the 24
positively identified compounds in LBG. Several compounds
(numbered as 242411, 198039, 243142, 240997, 207967, 246452,
243275, and 246475) induced acidification of the media at 25
µM, but failed to show a significant effect at 12.5 µM. One
compound (17191), however, induced acidification at a 12.5
µM concentration (Figure S2). We therefore selected compound
17191 for further study (herein referred to as iMAC, inducer of
Medium ACidification).
iMAC Induces V. Cholerae Cell Death in a
Glucose-Rich Environment, Which
Normally Stimulates Growth
We determined the chemical structure of iMAC, 5-(4-chloro-2-
nitrobenzoyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-
dione, as shown in Figure 2A. In order to further investigate
its effects on bacterial growth, we synthesized iMAC in a large
quantity for all subsequent experimental use. We found that
N16961 growth in LBG was significantly reduced by iMAC in
a dose-dependent manner (Figure 2B), and resulting OD600
values of N16961 cultures decreased as the iMAC concentration
increased. At iMAC concentrations <6.25 µM, we observed
no growth inhibition. Importantly, the iMAC-induced growth
defect was not observed in LB media, suggesting that iMAC
is only effective under glucose-enriched conditions. Of note,
the final OD600values of N16961 grown with 50 or 25 µM
iMAC were similar to that of LBG-grown 1alsS mutant, a
non-acetoin-producing strain that was used as a negative control
(Figure 2B). Moreover, the measured decrease in OD600 values
was concomitant with the loss of viability (Figure 2C). In LBG,
N16961 cells were completely killed after being treated with
iMAC at concentrations of 12.5 µM or greater.
Our results strongly suggest that glucose-dependent iMAC-
induced killing of N16961 occurs via the same mechanism
that causes the ∆alsS strain to lose viability under the same
conditions. In order to confirm this conclusion, we examined
changes in cell shape using SEM (as described in Materials
and Methods). As shown in Figure 2D, a typical curve-shape
morphology was observed in cells grown in LB. In contrast, we
observed spherically-shaped cells with knobby surfaces in LBG-
grown 1alsS mutant cells or in N16961 cells grown in LBG
+ iMAC (Figure 2D), conditions that lead to cell inviability.
Together, these results clearly demonstrate that iMAC renders
wild-type N16961 cells inviable under glucose-rich conditions,
despite the fact that abundant glucose typically enhances bacterial
growth.
iMAC Treatment Alters the Mode of
Glucose Fermentation in N16961 Cells
To better characterize the manner in which glucose metabolism
is influenced by iMAC treatment, we quantified an array of
extracellular metabolites and measured the amount of glucose
consumption in N16961 cells grown in LBG without or with
iMAC. We performed the same set of measurements for the
1alsS mutant strain as a control. Production of both lactic
and acetic acids was significantly greater in N16961 when
treated with iMAC (Figure 3A). The increased production of
these two major organic acids is roughly equivalent to that
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FIGURE 1 | Schematic diagram of the experimental procedures to identify chemical compounds that inhibit acetoin fermentation. (A) The strategy of
V. cholerae elimination using a chemical inhibitor that is capable of suppressing acetoin fermentation. (B) A high- throughput screening assay used to identify iMAC.
Bacterial cells were inoculated in LB or LBG (LB containing 1% glucose) on a 96-well plate containing glass beads for effective aeration and were grown in aerobic
conditions for 16 h. To verify the pH of culture supernatants, phenol-red was used as a pH indicator.
FIGURE 2 | N16961, the seventh pandemic El Tor strain, showed compromised viability in glucose-rich conditions in the presence of iMAC. (A) The
structure and IUPAC name of iMAC. (B) Bacterial cells were inoculated in LB or LBG with varying concentrations of iMAC and were grown for 16 h. Relative growth is
calculated from OD600 measurements. *p < 0.03 vs. OD600 values of LBG-grown cultures (iMAC untreated control). Data is presented as the mean ± SD (error bars)
determined from three independent replicate experiments. (C) Changes in cell viability after treatment with iMAC. Aliquots of each culture were sampled at 16 h
post-inoculation and were 10-fold serially diluted to assess the number of colony-forming units (CFUs). (D) Scanning electron microscope (SEM) images of V. cholerae
strains grown in LB or LBG, in both the presence and absence of 50 µM iMAC treatment. Cells were grown for 16 h prior to processing for SEM. The images were
acquired at 25,000x magnification.
of LBG-grown 1alsS cells. This suggests that the iMAC-
induced acidification was likely caused by accumulation of
organic acids during glucose metabolism and suggests that
mixed acid fermentation is stimulated by iMAC. When growth
media were buffered with 50mM phosphate to pH 7.5, the
resultant drop in pH was not significant, and bacterial cells
remained viable (Figure 3B). The production of ethanol and
acetoin, two neutral fermentation products, was induced only
in LBG-grown N16961, not in the control mutant strain
(Figure 3A). Interestingly, N16961 produced non-detectable
levels of ethanol and very little acetoin when treated with iMAC
(Figure 3A, red bars). Similar to the1alsSmutant, iMAC-treated
N16961 consumed only ∼25% of the initial dose of glucose
(Figure 3A) due to acidification and the resulting premature cell
death. Glucose was completely consumed by iMAC-untreated
N16961.
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FIGURE 3 | iMAC modulates glucose metabolism and results in high levels of organic acids and low levels of acetoin, a neutral fermentation product.
(A) Metabolite and glucose levels in the culture supernatant were measured using HPLC as described in the Materials and Methods. *p < 0.0001, **p < 0.05 vs.
metabolite levels that were measured in culture media of wild-type N16961 grown with LBG (iMAC untreated control). Non-detected values are displayed as “ND.”
Data are presented as the mean ± SD (error bars) based on three independent replicate experiments. (B) Wild type N16961 strain was inoculated in
phosphate-buffered (pH 7.5) or non-buffered LB/ LBG, respectively, either 50 µM iMAC treated or untreated, and were grown in aerobic conditions for 16 h. OD600
values were expressed as relative growth. *p < 0.05 vs. OD600 value grown in buffered LBG with iMAC. Three independent experiments were performed, and values
of mean ± SD (error bars) are displayed in each bar. (C) The acetoin level in the culture supernatant was measured by Voges-Proskauer (VP) tests for bacterial culture
supernatants. Bacteria were cultured in each media for 16 h. *p < 0.003 vs. acetoin levels in LBG grown cultures. (D) The promoter activity of the alsD (VC1589) gene
in wild-type N16961 strain grown in LB, LBG, or LBG + 50 µM iMAC for 4 h. The reporter strain containing chromosomal lacZ reporter fusion was assayed in
triplicate for β-galactosidase activity. Data are presented as the mean ± SD. *p < 0.002 vs. β-galactosidase activity of cells grown in LBG.
Acetoin production decreased as N16961 cells were treated
with increasing concentrations of iMAC (Figure 3C) in a dose-
dependent manner that is strikingly similar to that observed with
OD600 values (shown in Figure 2B). The capability to produce
acetoin, therefore, is critical for survival of N16961 under
glucose-rich growth conditions. To better define the molecular
mechanism by which iMAC modulates glucose metabolism,
we measured the promoter activity of the acetoin biosynthesis
operon in an N16961 reporter strain containing a palsD::lacZ
promoter fusion. N16961 cells were inoculated in LB, LBG,
or LBG + 50 µM iMAC and grown for 5 h before harvest.
Promoter activity was measured by β-galactosidase activity. The
alsD promoter activity of cells grown in LBG was significantly
greater than that of LB-grown cells (Figure 3D). However, the
induction of the alsD promoter was significantly lower with
iMAC treatment (Figure 3D). Together, these results suggest
that iMAC acts upstream of transcriptional activation of acetoin
biosynthesis gene.
iMAC Suppresses the Production of the
Stringent Response Regulator (p)ppGpp in
V. cholera
Recent work from our group has demonstrated that the
uninterrupted production of (p)ppGpp, a small nucleotide stress
alarmone, is necessary to ensure balanced glucose metabolism in
V. cholerae (Oh et al., 2015). Briefly, N16961 mutant cells that are
incapable of producing (p)ppGpp also demonstrated inviability
under glucose-rich conditions due to the acidification of their
environment that results from the uncontrolled production
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of organic acids. Based on these results, we hypothesized
that (p)ppGpp production is suppressed by iMAC treatment.
To test this possibility, we compared the effect of (p)ppGpp
deficiency with the effect of iMAC treatment in terms of
growth, medium acidification, and cell viability. N16961 and
its isogenic (p)ppGpp0 mutant (i.e., 1relA1relV1spoT mutant)
were inoculated in LB, LBG, or LBG + 50 µM iMAC and
incubated for 16 h. We found that iMAC suppressed N16961
growth and acidified N16961 cultures in the presence of
glucose to the same extent as the strain lacking (p)ppGpp
production (Figures S3A,B). Likewise, the (p)ppGpp0 mutant
also experienced environmental acidification in glucose-rich
conditions, comparable to the levels measured in N16961 cells
upon iMAC treatment (Figure S3C). Together, these results
strongly suggest that the molecular mechanism by which iMAC
affects V. cholerae is associated with the (p)ppGpp-dependent
regulation of glucose metabolism. In order to confirm this, we
measured the intracellular accumulation of (p)ppGpp with and
without iMAC treatment. As shown in Figure 4A, a P32-labeled
spot corresponding to ppGpp was substantially decreased in
iMAC-treated N16961. The same spot was not detected in the
(p)ppGpp0 mutant, confirming its lack of ppGpp production.
Prior work from our group has also demonstrated that
cholera toxin (CT) production is significantly induced during
anaerobic respiration after treatment with trimethylamine N-
oxide (TMAO), which provides an alternative electron acceptor
(Lee et al., 2012). Further, this increased production was
suppressed when V. cholerae was unable to produce (p)ppGpp
(Oh et al., 2014). In addition, CT production during the
AKI condition (a biphasic growth to promote CT production;
Iwanaga et al., 1986) is dependent on the cell’s capability to
FIGURE 4 | Effects of iMAC on (p)ppGpp-dependent acetoin
production. (A) Intracellular (p)ppGpp levels were detected using TLC
analysis. Wild-type N16961 and (p)ppGpp0 mutant (1relA 1spoT 1relV triple
genes deletion mutant) were grown in LB or LB + 50 µM iMAC with
P32-orthophosphate for 4 h. Cellular extracts were prepared as described in
the Materials and Methods and analyzed using TLC. (B) CT levels in the
culture supernatants were measured by CT-ELISA. Wild-type N16961 and
(p)ppGpp0 mutant were grown under two different CT-inducible culture
conditions as described in Materials and Methods. *p < 0.003 vs. CT levels
produced under grown in plain LB. **p < 0.03 vs. CT levels of N16961
produced under grown in LBT. Data presented as the mean ± SD based on
three independent replicate experiments.
produce (p)ppGpp (Oh et al., 2014). To investigate whether
inhibition of (p)ppGpp production by iMAC treatment affects
CT production, we measured the degree to which CT production
is altered under each of these two conditions that normally
stimulate CT production. We found that CT production was
significantly decreased after iMAC treatment during anaerobic
TMAO respiration (Figure 4B), although not as significantly
was observed in the (p)ppGpp0 mutant. Additionally, iMAC
treatment caused decreased CT production under the AKI
condition (Figure 4B). Together, these results indicate that
iMAC treatment causes V. cholerae wild-type cells to produce
significantly less (p)ppGpp, an important regulator of the
bacterial stringent response and virulence.
Treatment with iMAC Attenuated the
Colonization of V. cholerae in
Glucose-Enriched In vivo Conditions
Next, we sought to characterize the effect of iMAC treatment
on V. cholerae colonization and virulence in vivo by utilizing an
infant mouse infection model. Six-day-old neonatal mice were
infected with N16961 cells resuspended in LB or LBG media,
both with and without the addition of 50 µM iMAC. When
viable cells recovered from mouse intestine were enumerated, we
found a significant decrease in CFU in mice infected with cells
from media containing both glucose and iMAC (Figure 5A). No
meaningful differences, however, were observed among the LB,
LB + iMAC, and LBG groups (Figure 5A). Fluid accumulation
(FA), a phenotype primarily caused by the presence of CT during
infection, was also decreased in mice infected with bacterial
cells prepared in LBG + iMAC (Figure 5B). Again, iMAC in
LB exerted no effect on FA, which is consistent with previous
findings that iMAC-mediated effects occur only in glucose-rich
environments. This result is also consistent with our findings that
iMAC suppresses CT production in glucose-rich environments
(Figure 4B).
We next sought to assess whether iMAC treatment
demonstrates any negative side-effects on host tissue cells.
We cultured human intestinal epithelial cells (HT29) that were
treated with iMAC and found no significant damage. Even when
treated with increasing iMAC concentrations, no significant
damage occurred (Figure S4A). Morphological change, typically
an indication of cytotoxicity, was observed in HT29 cells treated
with silver nanoparticles, which were used as a positive control
agent (Figure S4A). After 48 h of treatment, MTT assays were
performed to further confirm the lack of compromised epithelial
cell viability after iMAC treatment. Whereas silver nano-particles
exerted a clear cytotoxic effect on HT29 cells, iMAC treatment
even at high concentrations failed to elicit any cytotoxic effect
(Figure S4B).
Several V. cholerae Strains with Different
Serotypes Show Similar Effects after iMAC
Treatment
Evidence suggests that cholera pandemics and outbreaks are
caused by V. cholerae strains of O1 or O139 serogroups. Other
serogroups are sometimes associated with sporadic cholera-like
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FIGURE 5 | Effects of iMAC on V. cholerae in vivo infectivity. Infant mice (n > 8) were infected with 50 µL of each V. cholerae N16961 strain (1 × 106 cells)
suspended in indicated media supplemented with or without 50 µM iMAC. After 24 h, mice were sacrificed, and the entire intestines were extracted. (A) The number
of viable cells was measured after 16 h by counting the number of viable bacterial cells recovered from the mouse intestine. The solid horizontal lines represent the
geometric mean of each sample. *p < 0.001 vs. CFU from infection with LB, LB + iMAC, or LBG. Each symbol shows the value obtained from each mouse. (B) The
fluid accumulation ratio was calculated as described in Materials and Methods. Data are presented as the mean ± SD based on three independent replicate
experiments. *p < 0.001 vs. fluid accumulation ratio from uninfected control, **p < 0.004 vs. fluid accumulation ratio from infection with LB, LB+iMAC, or LBG.
diarrhea or localized outbreaks. The seventh cholera pandemic
was caused byO1 serotype El Tor biotype strains, which gradually
replaced the O1 classical biotype strains (Kim et al., 2015). The
O139 serotype strains have also caused major endemic cholera
(Barrett and Blake, 1981; Banerjee et al., 2014). Furthermore,
O5 and O37 serogroups (referred to as non-O1/non-O139) have
caused devastating cholera outbreaks in Czechoslovakia and
Sudan, respectively (Aldová et al., 1968; Yamaichi et al., 1999;
Rahaman et al., 2015). Given the diverse serotypes that show
important clinical relevance, we investigated whether iMAC
treatment causes similar glucose-dependent effects on viability
in diverse V. cholerae strains. For this, we tested 22 different V.
cholerae strains that were originally isolated either from patient
samples or from the environment. We also included two related
Vibrio species, as well as Pseudomonas aeruginosa and Escherichia
coli. All strains were grown in LB or LBGmedium in the presence
or absence of 50 µM iMAC. After 16 h of growth, the pH
of the media was measured, and the viability of the cells was
determined, as summarized in Table 1. The O1 classical biotype
strains showed a sharp decrease in viability in LBG media even
without iMAC treatment, which is consistent with a previous
report (Yoon and Mekalanos, 2006). Enhanced growth, however,
was observed in all other V. cholerae strains, indicating that they
can effectively metabolize glucose, leading to enhanced growth
(Table 1). Importantly, we observed significant acidification of
the media and decreased viability when all 21 of these robust
“glucose metabolizers” were treated with iMAC. Other related
Vibrio strains, including V. vulnificus and V. paraheamolyticus,
showed no significant effects as a result of iMAC treatment,
and they retained high viability in glucose-rich environments
irrespective of the presence of iMAC (Table 1). These results
strongly suggest that the effects of iMAC on glucose-dependent
viability are specific and highly efficient in targeting V. cholerae
strains, with no evident effects on other species or on host tissue
cells.
DISCUSSION
Antibiotic-resistant strains of V. cholerae have been reported
in the last decade; as such, it is vitally important to identify
new concept antibiotics and/or develop novel therapeutics
that can replace or otherwise supplement conventional cholera
treatment (Kitaoka et al., 2011; Gupta et al., 2016). Previous
work from theMekalanos group has shown that a small-molecule
inhibitor of V. cholerae virulence (known as virstatin; Hung
et al., 2005) successfully represses CT and TCP production by
inhibiting the dimerization of N-terminal domain of ToxT, a
major virulence transcriptional activator (Shakhnovich et al.,
2007a; Childers et al., 2011). Because virstatin specifically targets
virulence, it has clinical use against many toxigenic V. cholerae
strains that have emerged from O1/O139 serotypes. Virstatin
resistance, however, has recently emerged in V. cholerae strains
derived from non-O1/non-O139 serogroups that have recently
caused sporadic outbreaks (Shakhnovich et al., 2007b). This
highlights the importance of identifying new antibiotics that
target V. cholerae cells via a common molecular mechanism.
While V. cholerae is quite tolerant to alkaline conditions, it is
highly sensitive to even mildly acidic conditions, a potential
vulnerability that could be exploited in clinical treatments
(Finkelstein, 1996). Because iMAC targets this physiological
characteristic that is a conserved mechanism of V. cholerae, it
exhibits broad applicability, suggesting a more effective common
antibiotic against cholera.
We successfully identified iMAC as a result of the following
contributions. First, we used a detection method of medium
acidification that used a pH indicator and glass beads, the latter
of which effectively homogenized the media with gentle shaking
and therefore reflected an accurate pH measurement, which
also enabled us to screen in a high-throughput format. Second,
it is known that glucose metabolism in V. cholerae bifurcates
into two major pathways, one that produces organic acids and
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TABLE 1 | Impact of iMAC on various V. cholerae strains and other related bacterial species.
Bacterial strain Strain pH of culture media* Cell viability**
LB LB + iMAC LBG LBG + iMAC LB LB + iMAC LBG LBG + iMAC
V. cholera O1, Classical GP8 8.58 (±0.58) 8.69 (±0.03) 4.73 (±0.36) 4.98 (±0.09) V V NV NV
A68 8.65 (±0.03) 8.69 (±0.01) 4.41(±0.01) 4.89 (±0.02) V V NV NV
0395 9.12 (±0.18) 9.00 (±0.33) 4.90 (±0.02) 5.02 (±0.17) V V NV NV
5698 7.62 (±0.21) 7.76 (±0.26) 4.90 (±0.01) 5.13 (±0.05) V V NV NV
A76 8.73 (±0.04) 8.78 (±0.06) 4.72 (±0.02) 5.10 (±0.01) V V NV NV
O1, El Tor N16961 8.72 (±0.01) 8.74 (±0.02) 8.56 (±0.01) 4.95 (±0.03) V V V NV
A10 8.79 (±0.03) 8.82 (±0.02) 8.47 (±0.06) 4.99 (±0.01) V V V NV
A18 8.74 (±0.06) 8.80 (±0.01) 8.25 (±0.09) 4.85 (±0.05) V V V NV
A152 8.85 (±0.05) 8.81 (±0.05) 8.48 (±0.01) 4.97 (±0.08) V V V NV
A22 8.79 (±0.03) 8.83 (±0.02) 8.57 (±0.10) 4.91 (±0.12) V V V NV
O1, South America A200 8.72 (±0.03) 8.73 (±0.01) 8.60 (±0.03) 4.87 (±0.11) V V V NV
A177 8.79 (±0.03) 8.81 (±0.03) 8.48 (±0.10) 5.00 (±0.09) V V V NV
O1, US-Gulf A213 8.62 (±0.01) 8.71 (±0.03) 8.51 (±0.03) 4.86 (±0.05) V V V NV
A217 8.74 (±0.02) 8.80 (±0.02) 8.88 (±0.41) 5.08 (±0.10) V V V NV
O139 M010 9.15 (±0.14) 9.19 (±0.10) 8.83 (±0.03) 5.06 (±0.03) V V V NV
AR-196157 8.73 (±0.10) 8.72 (±0.01) 7.81 (±0.05) 5.08 (±0.06) V V V NV
2206252 8.77 (±0.02) 8.77 (±0.05) 7.51 (±0.10) 5.45 (±0.66) V V V NV
non-O1, non-O139 12/E-1776 8.78 (±0.12) 8.76 (±0.04) 8.58 (±0.01) 4.91 (±0.02) V V V NV
14/E-1777 8.68 (±0.04) 8.63 (±0.22) 8.42 (±0.04) 4.81 (±0.03) V V V NV
15/E-1877 8.82 (±0.04) 8.79 (±0.11) 8.64 (±0.21) 4.82 (±0.21) V V V NV
A325 8.72(±0.01) 8.73 (±0.01) 8.55 (±0.11) 4.87 (±0.04) V V V NV
A215 8.68 (±0 03) 8.80 (±0.01) 8.55 (±0.04) 4.91 (±0.06) V V V NV
V. vulnificus M06-24/0 9.01 (±0.10) 9.08 (±0.09) 8.96 (±0.08) 9.00 (±0.11) V V V V
V. paraheamolyticus ATCC 27519 9.07 (±0.08) 9.04 (±0.01) 9.01 (±0.02) 9.02 (±0.03) V V V V
P. aeruginosa PA01 9.13 (±003) 9.20 (±0.05 8.70 (±0.12) 8.62 (±0.05) V V V V
E. coli DH5a 8.66 (±0.19) 8.70 (±0.21) 4.72 (±0.09) 4.71 (±0.13) V V V V
*pH values <5.5 are shown in bold. ** V, viable/NV, non-viable.
another that produces neutral end-products including acetoin
and ethanol. Upon activation, acetoin production suppresses
the production of organic acids, and vice versa. This suggests
that modulating glucose metabolism toward the production of
organic acids can provide a novel strategy for the targeted
killing of V. cholerae cells. This potential is further bolstered
by the fact that V. cholerae is highly sensitive to acid stress
in its environment (Merrell and Camilli, 2000). Based on
our results in Table 1, the E. coli strain DH5α maintained
its viability down to a pH of ∼4.7, while all V. cholerae
strains were inviable at pH around 5.0. Finally, a V. cholerae
mutant that cannot produce (p)ppGpp also becomes inviable in
glucose-rich conditions (Oh et al., 2015). This previous finding
suggests that (i) any chemical that interferes with (p)ppGpp
production or antagonizes its action can cause inviability
under glucose-rich environments and, (ii) therefore, V. cholerae
glucose metabolism provides an excellent target for chemical
treatment.
One of the long-standing questions in cholera epidemiology
is how the El Tor biotype strains came to replace classical
biotype strains (Pradhan et al., 2013; Kim et al., 2014). Our
work shows that the classical biotype strains cannot conduct
acetoin production during glucose fermentation even in LBG
medium (Table 1), a phenotype identical to that of the N16961
(p)ppGpp0 mutant. This suggests that the classical biotype strains
might have been less competent than the El Tor biotype in
producing (p)ppGpp under glucose-rich conditions, such as
those commonly found in the human intestinal environment.
This also suggests that El Tor biotype strains have evolved to
more efficiently mount the stringent response (SR), which would
further increase their fitness in the hostile host intestine relative
to the classical biotype strains. Of note, classical biotypes have
commonly been considered to be more virulent than the El
Tor strains. The production of CT and TCP by the classical
strains was significantly greater in vivo than in the El Tor strains
(Turnbull et al., 1985; Jonson et al., 1992). In addition, the
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FIGURE 6 | A potential mechanism by which iMAC, acting as a
ppGpp-dependent metabolic switch, induces inviability of V. cholerae.
In the presence of glucose, V. cholerae normally metabolize glucose by the
mixed acid fermentation during early stages. As growth proceeds, the
environmental pH decreases as a result of the accumulation of organic acid
metabolites. The glucose metabolic pathway then switches to acetoin
fermentation to avoid lethal acidification. Previous work demonstrates that
intracellular (p)ppGpp has a critical role in this glucose metabolic switch. Here,
iMAC is characterized in terms of its potential role in inhibiting the
accumulation of intracellular (p)ppGpp. Overall, iMAC successfully prevents the
ppGpp-dependent glucose metabolic switch by inhibiting the accumulation of
intracellular ppGpp. As a result, cells lose their viability as their environment
becomes acidified as a result of uncontrolled organic acid fermentation in
glucose-enriched conditions.
classical strains exhibit higher expression of virulence-associated
genes (Beyhan et al., 2006). Petritsch and colleagues have also
reported that diarrheal volumes increase when higher levels of
CT are found inside the human intestine (Petritsch et al., 1992).
Rapid bacterial expulsions, therefore, might have occurred more
frequently during infection by classical biotype strains compared
to the El Tor strains. Along these lines, it is thought that El Tor
biotype strains were better adapted to the host intestine by having
lower virulence expression and increased capability to activate
SR, allowing the El Tor strains to outcompete the classical strains
in nature.
The stringent response (SR), which is activated under
conditions of nutrient starvation, also plays an important role in
regulating bacterial virulence (Dalebroux et al., 2010). Previous
work from our group has demonstrated that, in V. cholerae,
(p)ppGpp is required for glucose metabolism, and its production
is essential for bacterial growth (Oh et al., 2015) and CT
production (Oh et al., 2014). These findings raise the possibility
that: (i) (p)ppGpp regulates a common mechanism that controls
both bacterial metabolism and virulence (two features that
otherwise appear to be distinctly regulated); and (ii) that
intervening and blocking this mechanism provides a promising
alternative to treat V. cholerae infection. Recently, Wexselblatt
and colleagues showed that a chemical compound (which they
termed “relacin”) suppresses the production of (p)ppGpp in
Gram-positive bacterial species (Wexselblatt et al., 2012). Relacin
is an analog of (p)ppGpp, and it was found to inhibit RelA, a
conserved enzyme responsible for (p)ppGpp synthesis. However,
relacin is required in significant quantities (∼mM levels) in order
to exert an inhibitory effect on bacterial growth and/or viability.
Our results indicate that a relatively low concentration of
iMAC (12.5 µM) successfully suppresses (p)ppGpp production
and other downstream events. Although more experiments are
necessary to precisely define the molecular mechanisms by which
iMAC represses (p)ppGpp production, it is nonetheless clear that
iMAC-mediated regulation occurs much more efficiently than
that by relacin.
We also tested the effect of iMAC on several El Tor strains,
including four prototype El Tor strains collected in south Asia
andMozambique, two strains collected during cholera epidemics
in Latin America in 1990s, and two U.S. Gulf-Coast strains that
are considered to be pre-seventh pandemic strain (Mutreja et al.,
2011). Three O139 serogroup strains, which are considered to
be a subgroup within El Tor biotype strains, were also tested.
Medium acidification and reduced viability after treatment with
iMAC in glucose-rich conditions were common phenomena for
all of the tested V. cholerae strains, demonstrating that iMAC
exerts its effect generally across the El Tor strains.
In conclusion, we identified a novel compound that
specifically kills V. cholerae in glucose-rich environments
via a mechanism that suppresses (p)ppGpp production. We
propose that iMAC acts as a metabolic switch to inhibit
acetoin fermentation (as summarized in Figure 6). We also
show that iMAC elicits no clear toxicity to human cells
or other more distantly related bacteria. These findings
suggest that iMAC could be a highly effective tool for
treating V. cholerae infections. In particular, we suggest
that iMAC could potentially act synergistically with oral
rehydration solution (ORS) therapy, because the continuous
administration of ORS creates a glucose-rich environment
in the host intestine within a short time. We expect these
results to help establish better strategies for treating cholera
patients.
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